Tomoki Muramatsu

1.8k total citations
29 papers, 1.4k citations indexed

About

Tomoki Muramatsu is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Tomoki Muramatsu has authored 29 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Molecular Biology, 7 papers in Cancer Research and 6 papers in Oncology. Recurrent topics in Tomoki Muramatsu's work include Cancer-related gene regulation (8 papers), Epigenetics and DNA Methylation (6 papers) and MicroRNA in disease regulation (5 papers). Tomoki Muramatsu is often cited by papers focused on Cancer-related gene regulation (8 papers), Epigenetics and DNA Methylation (6 papers) and MicroRNA in disease regulation (5 papers). Tomoki Muramatsu collaborates with scholars based in Japan, United States and Israel. Tomoki Muramatsu's co-authors include Johji Inazawa, Issei Imoto, Hitoshi Tsuda, Tatsuyuki Kawano, Yutaka Shimada, Koji Ueda, Ken‐ichi Kozaki, Shigeo Haruki, Marius Sudol and Takeshi Matsui and has published in prestigious journals such as PLoS ONE, Cancer Research and Oncogene.

In The Last Decade

Tomoki Muramatsu

29 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tomoki Muramatsu Japan 20 1.1k 526 300 277 100 29 1.4k
Katharine M. Hardy United States 14 940 0.9× 340 0.6× 212 0.7× 464 1.7× 106 1.1× 16 1.2k
Karen D. Cowden Dahl United States 15 678 0.6× 432 0.8× 120 0.4× 277 1.0× 141 1.4× 26 1.1k
Sylvie Thuault France 15 1.0k 0.9× 388 0.7× 147 0.5× 421 1.5× 70 0.7× 18 1.3k
Irina Elcheva United States 16 1.1k 1.0× 445 0.8× 112 0.4× 185 0.7× 123 1.2× 26 1.2k
Ahmed S. Warda Germany 6 2.4k 2.2× 691 1.3× 258 0.9× 470 1.7× 78 0.8× 6 2.7k
Pavlova Tv Russia 19 657 0.6× 287 0.5× 152 0.5× 216 0.8× 70 0.7× 47 947
Jun Niu China 20 496 0.5× 360 0.7× 184 0.6× 471 1.7× 157 1.6× 43 1.2k
Shi-Juan Mai China 16 690 0.6× 306 0.6× 127 0.4× 242 0.9× 90 0.9× 19 981
Htoo Zarni Oo Canada 21 743 0.7× 347 0.7× 112 0.4× 453 1.6× 121 1.2× 54 1.2k

Countries citing papers authored by Tomoki Muramatsu

Since Specialization
Citations

This map shows the geographic impact of Tomoki Muramatsu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tomoki Muramatsu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tomoki Muramatsu more than expected).

Fields of papers citing papers by Tomoki Muramatsu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tomoki Muramatsu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tomoki Muramatsu. The network helps show where Tomoki Muramatsu may publish in the future.

Co-authorship network of co-authors of Tomoki Muramatsu

This figure shows the co-authorship network connecting the top 25 collaborators of Tomoki Muramatsu. A scholar is included among the top collaborators of Tomoki Muramatsu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tomoki Muramatsu. Tomoki Muramatsu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Muramatsu, Tomoki, Hidetsugu Suzuki, Kazuyuki Fukushima, et al.. (2023). Identification of a Biallelic Missense Variant in Gasdermin D ( c.823G > C, p.Asp275His ) in a Patient of Atypical Gorham‐Stout Disease in a Consanguineous Family. JBMR Plus. 7(9). e10784–e10784. 4 indexed citations
2.
Gen, Yasuyuki, Tomoki Muramatsu, Jun Inoue, & Johji Inazawa. (2021). miR-766-5p Targets Super-Enhancers by Downregulating CBP and BRD4. Cancer Research. 81(20). 5190–5201. 19 indexed citations
3.
Liu, Chang, Yasuyuki Gen, Kousuke Tanimoto, et al.. (2021). Concurrent targeting of MAP3K3 and BRD4 by miR-3140-3p overcomes acquired resistance to BET inhibitors in neuroblastoma cells. Molecular Therapy — Nucleic Acids. 25. 83–92. 4 indexed citations
4.
Yoshimatsu, Yasuhiro, Tomoki Muramatsu, Keiko Mitani, et al.. (2021). Isolation and characterisation of lymphatic endothelial cells from lung tissues affected by lymphangioleiomyomatosis. Scientific Reports. 11(1). 8406–8406. 13 indexed citations
5.
Xu, Bo, Tomoki Muramatsu, & Johji Inazawa. (2020). Suppression of MET Signaling Mediated by Pitavastatin and Capmatinib Inhibits Oral and Esophageal Cancer Cell Growth. Molecular Cancer Research. 19(4). 585–597. 14 indexed citations
6.
Deryugina, Elena I., Ewa Zając, Lior Zilberberg, et al.. (2018). LTBP3 promotes early metastatic events during cancer cell dissemination. Oncogene. 37(14). 1815–1829. 21 indexed citations
7.
Takahashi, Kazuki, Katarzyna A. Podyma‐Inoue, Yasuhiro Yoshimatsu, et al.. (2018). Regulatory Role of Transforming Growth Factor-β Signals in the Migration and Tumor Formation of HOC313-LM cells, an Oral Squamous Cell Carcinoma. THE JOURNAL OF THE STOMATOLOGICAL SOCIETY JAPAN. 85(2). 52–61. 2 indexed citations
8.
Gen, Yasuyuki, Tomoki Muramatsu, Hidekazu Hiramoto, et al.. (2018). miR-3140 suppresses tumor cell growth by targeting BRD4 via its coding sequence and downregulates the BRD4-NUT fusion oncoprotein. Scientific Reports. 8(1). 4482–4482. 26 indexed citations
9.
Hiramoto, Hidekazu, Tomoki Muramatsu, Daisuke Ichikawa, et al.. (2017). miR-509-5p and miR-1243 increase the sensitivity to gemcitabine by inhibiting epithelial-mesenchymal transition in pancreatic cancer. Scientific Reports. 7(1). 4002–4002. 51 indexed citations
10.
Muramatsu, Tomoki, Seiya Imoto, Rui Yamaguchi, et al.. (2016). The hypusine cascade promotes cancer progression and metastasis through the regulation of RhoA in squamous cell carcinoma. Oncogene. 35(40). 5304–5316. 30 indexed citations
11.
Muramatsu, Tomoki, et al.. (2016). Exosomal microRNA miR-1246 induces cell motility and invasion through the regulation of DENND2D in oral squamous cell carcinoma. Scientific Reports. 6(1). 38750–38750. 163 indexed citations
12.
Okada, Yukinori, Tomoki Muramatsu, Masahiro Kanai, et al.. (2016). Significant impact of miRNA–target gene networks on genetics of human complex traits. Scientific Reports. 6(1). 22223–22223. 31 indexed citations
13.
Muramatsu, Tomoki, et al.. (2015). miR-544ainduces epithelial–mesenchymal transition through the activation of WNT signaling pathway in gastric cancer. Carcinogenesis. 36(11). 1363–1371. 71 indexed citations
14.
Harazono, Yosuke, Tomoki Muramatsu, Narikazu Uzawa, et al.. (2013). miR-655 Is an EMT-Suppressive MicroRNA Targeting ZEB1 and TGFBR2. PLoS ONE. 8(5). e62757–e62757. 93 indexed citations
15.
Matsumura, Satoshi, Issei Imoto, Ken‐ichi Kozaki, et al.. (2012). Integrative Array-Based Approach Identifies MZB1 as a Frequently Methylated Putative Tumor Suppressor in Hepatocellular Carcinoma. Clinical Cancer Research. 18(13). 3541–3551. 25 indexed citations
16.
Gaffney, Christian J., Tsutomu Oka, Virginia Mazack, et al.. (2012). Identification, basic characterization and evolutionary analysis of differentially spliced mRNA isoforms of human YAP1 gene. Gene. 509(2). 215–222. 82 indexed citations
17.
KURASAWA, Y., Ken‐ichi Kozaki, Atiphan Pimkhaokham, et al.. (2011). Stabilization of phenotypic plasticity through mesenchymal-specific DNA hypermethylation in cancer cells. Oncogene. 31(15). 1963–1974. 9 indexed citations
18.
Haruki, Shigeo, Issei Imoto, Ken‐ichi Kozaki, et al.. (2010). Frequent silencing of protocadherin 17 , a candidate tumour suppressor for esophageal squamous cell carcinoma. Carcinogenesis. 31(6). 1027–1036. 82 indexed citations
19.
Komatsu, Shuhei, Issei Imoto, Hitoshi Tsuda, et al.. (2009). Overexpression of SMYD2 relates to tumor cell proliferation and malignant outcome of esophageal squamous cell carcinoma. Carcinogenesis. 30(7). 1139–1146. 144 indexed citations
20.
Goto, Yuya, et al.. (2006). JPO1/CDCA7, a novel transcription factor E2F1-induced protein, possesses intrinsic transcriptional regulator activity. Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression. 1759(1-2). 60–68. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Katharine M. Hardy Breakdown of academic impact, for papers by Karen D. Cowden Dahl Breakdown of academic impact, for papers by Sylvie Thuault Breakdown of academic impact, for papers by Irina Elcheva Breakdown of academic impact, for papers by Ahmed S. Warda Breakdown of academic impact, for papers by Pavlova Tv Breakdown of academic impact, for papers by Jun Niu Breakdown of academic impact, for papers by Shi-Juan Mai Breakdown of academic impact, for papers by Htoo Zarni Oo
Rankless by CCL
2026